Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellebrite DI Ltd. covers the month of September 2025. The report serves to announce the results of the Company's Annual General Meeting of Shareholders held on September 19, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder voting outcomes rather than a financial performance statement.
Material Changes
No material financial changes versus prior periods are reported in this filing. The primary event is the successful approval of all proposals presented at the Annual General Meeting.
Guidance, Outlook, and Management Commentary
Management commentary is limited to the confirmation that all shareholder proposals were approved by the requisite majority under Israeli Companies Law. No specific financial guidance, outlook, risks, or contingencies are detailed in this specific text.
Key Facts for Investor Verification
- All proposals at the September 19, 2025 Annual General Meeting were approved by shareholders.
- 188,039,771 ordinary shares were present or represented by proxy at the meeting.
- Attendance represented approximately 76.82% of the issued and outstanding ordinary shares as of the record date.
- The filing incorporates by reference into registration statements on Form S-8 and Form F-3.